|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.75 NOK | +5.47% |
|
-0.74% | -43.75% |
EXACT Therapeutics AS reported earnings results for the half year ended June 30, 2023. For the half year, the company reported revenue was NOK 0.004458 million compared to NOK 0.00593 million a year ago. Net loss was NOK 22.8 million compared to NOK 26.91 million a year ago.
Basic loss per share from continuing operations was NOK 0.76 compared to NOK 0.9 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -43.75% | 19.97M | |
| +25.69% | 47.9B | |
| +46.90% | 41.42B | |
| -3.46% | 40.7B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +0.17% | 12.15B | |
| +28.07% | 12.14B | |
| -1.24% | 11.99B |
EXACT THERAPEUTICS 
